Regeneron Pharmaceuticals Corporate Presentation 2023

Regeneron Pharmaceuticals' November 2023 corporate presentation outlines the company's pipeline of marketed products and product candidates, including EYLEA, Dupixent, Libtayo, and multiple late-stage investigational therapies. The presentation contains forward-looking statements regarding regulatory milestones, commercial launches, and financial guidance for the biopharmaceutical company.